Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAFNA PHARMA vs SHARON BIO-MEDICINE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAFNA PHARMA SHARON BIO-MEDICINE BAFNA PHARMA/
SHARON BIO-MEDICINE
 
P/E (TTM) x 476.3 0.1 490,000.1% View Chart
P/BV x 2.4 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BAFNA PHARMA   SHARON BIO-MEDICINE
EQUITY SHARE DATA
    BAFNA PHARMA
Mar-24
SHARON BIO-MEDICINE
Mar-23
BAFNA PHARMA/
SHARON BIO-MEDICINE
5-Yr Chart
Click to enlarge
High Rs126NA-   
Low Rs77NA-   
Sales per share (Unadj.) Rs64.4338.5 19.0%  
Earnings per share (Unadj.) Rs3.133.0 9.4%  
Cash flow per share (Unadj.) Rs5.251.6 10.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs34.2-1,024.9 -3.3%  
Shares outstanding (eoy) m23.665.76 410.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.60-   
Avg P/E ratio x32.50-  
P/CF ratio (eoy) x19.40-  
Price / Book Value ratio x3.00-  
Dividend payout %00-   
Avg Mkt Cap Rs m2,3900-   
No. of employees `000NANA-   
Total wages/salary Rs m190333 57.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,5251,950 78.2%  
Other income Rs m3545 79.0%   
Total revenues Rs m1,5601,994 78.2%   
Gross profit Rs m111254 43.8%  
Depreciation Rs m50107 46.5%   
Interest Rs m231 3,693.5%   
Profit before tax Rs m73190 38.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m00-   
Profit after tax Rs m73190 38.7%  
Gross profit margin %7.313.0 56.0%  
Effective tax rate %00-   
Net profit margin %4.89.7 49.4%  
BALANCE SHEET DATA
Current assets Rs m9451,758 53.7%   
Current liabilities Rs m5413,391 16.0%   
Net working cap to sales %26.5-83.7 -31.6%  
Current ratio x1.70.5 336.9%  
Inventory Days Days217 10.3%  
Debtors Days Days1,087488 222.6%  
Net fixed assets Rs m5321,372 38.8%   
Share capital Rs m23712 2,055.3%   
"Free" reserves Rs m572-5,915 -9.7%   
Net worth Rs m808-5,903 -13.7%   
Long term debt Rs m1085,580 1.9%   
Total assets Rs m1,4773,130 47.2%  
Interest coverage x4.2307.5 1.4%   
Debt to equity ratio x0.1-0.9 -14.1%  
Sales to assets ratio x1.00.6 165.8%   
Return on assets %6.56.1 107.1%  
Return on equity %9.1-3.2 -282.3%  
Return on capital %10.5-59.0 -17.8%  
Exports to sales %073.2 0.0%   
Imports to sales %07.5 0.0%   
Exports (fob) Rs mNA1,428 0.0%   
Imports (cif) Rs mNA145 0.0%   
Fx inflow Rs m01,428 0.0%   
Fx outflow Rs m0166 0.0%   
Net fx Rs m01,263 0.0%   
CASH FLOW
From Operations Rs m95411 23.1%  
From Investments Rs m-151-28 542.9%  
From Financial Activity Rs m-8NA -3,673.9%  
Net Cashflow Rs m-64384 -16.7%  

Share Holding

Indian Promoters % 88.3 0.0 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 11.7 100.0 11.7%  
Shareholders   7,295 24,837 29.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAFNA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on BAFNA PHARM. vs SHARON BIO-MEDICINE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAFNA PHARM. vs SHARON BIO-MEDICINE Share Price Performance

Period BAFNA PHARM. SHARON BIO-MEDICINE S&P BSE HEALTHCARE
1-Day 2.17% -1.53% 1.13%
1-Month 0.99% -8.29% 1.45%
1-Year -7.11% -41.85% 46.53%
3-Year CAGR -13.04% -33.57% 19.71%
5-Year CAGR 73.16% -40.63% 26.17%

* Compound Annual Growth Rate

Here are more details on the BAFNA PHARM. share price and the SHARON BIO-MEDICINE share price.

Moving on to shareholding structures...

The promoters of BAFNA PHARM. hold a 88.3% stake in the company. In case of SHARON BIO-MEDICINE the stake stands at 0.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAFNA PHARM. and the shareholding pattern of SHARON BIO-MEDICINE.

Finally, a word on dividends...

In the most recent financial year, BAFNA PHARM. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

SHARON BIO-MEDICINE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BAFNA PHARM., and the dividend history of SHARON BIO-MEDICINE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.